Top Markets
#1 ADO Protocol ADO Protocol +329.72%
#2 GoPlus Security GoPlus Security +51.65%
#3 Nockchain Nockchain +47.38%
#4 Tutorial Tutorial +42.31%
#5 Starpower Starpower +33.22%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +30.91%
#7 The Black Bull The Black Bull +27.75%
#8 GAIB AID GAIB AID +24.67%
#9 Casper Network Casper Network +17.77%
#10 Verus Coin Verus Coin +16.89%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Britannia Life Sciences Inc. Britannia Life Sciences Inc.

Britannia Life Sciences Inc.

BLAB
Rank in Stocks #33391
Britannia Life Sciences Inc., headquartered in Toronto, Canada, offers... Britannia Life Sciences Inc., headquartered in Toronto, Canada, offers specialized services in rigorous product evaluation, comprehensive safety analysis, and adherence to regulatory standards. The company supports businesses within the cosmetics, nutraceutical, and consumer packaged goods (CPG) sectors, operating extensively throughout the United Kingdom and various international markets.
Share Price
$0.0477059
Market Cap
$7.74M
Change (1 day)
0.00%
Change (1 year)
-5.82%
Country
CA
Trade Britannia Life Sciences Inc. (BLAB)

Category

Healthcare
Revenue for Britannia Life Sciences Inc. (BLAB)
Revenue in Aug 2026 TTM: 0
According to Britannia Life Sciences Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Britannia Life Sciences Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE